Overview Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects Status: Completed Trial end date: 2014-02-01 Target enrollment: Participant gender: Summary This is a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation in depressed human subjects study. Phase: Phase 1 Details Lead Sponsor: Neuralstem Inc.